Balaji Healthline

Olacitinib 5.4 mg tablets contain Olacitinib as the active pharmaceutical ingredient, formulated to deliver 5.4 mg per tablet. The medication is blended with standard excipients such as diluents, binders, disintegrants, and lubricants to ensure tablet stability, uniformity, and proper dissolution. These inactive ingredients may include microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, povidone, and magnesium stearate, depending on the manufacturer’s formulation. The tablet is designed to provide consistent bioavailability and therapeutic effectiveness while maintaining quality and patient safety standards.

Meloxicam Oral Suspension is commonly formulated as a non-steroidal anti-inflammatory drug (NSAID) often used alone or in combination with other supportive agents to manage pain and inflammation associated with conditions like osteoarthritis, rheumatoid arthritis, or juvenile idiopathic arthritis. In some formulations, it may be combined with agents such as paracetamol (acetaminophen) to enhance analgesic effects or with antacids like magnesium or aluminum hydroxide to minimize gastrointestinal irritation. Meloxicam works by selectively inhibiting cyclooxygenase-2 (COX-2), thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. The oral suspension form ensures accurate dosing and ease of administration, especially in pediatric or elderly patients who may have difficulty swallowing tablets. Combination formulations, when present, aim to offer synergistic pain relief while improving tolerability.

Carprofen 100 mg Chewable Tablets contain Carprofen, a non-steroidal anti-inflammatory drug (NSAID) used in dogs for pain relief and inflammation control, particularly in osteoarthritis and postoperative recovery. Each chewable tablet is formulated with 100 mg of Carprofen as the active ingredient, combined with palatable excipients such as flavoring agents, fillers, and stabilizers to create a dog-friendly chewable form. These inactive ingredients help ensure proper tablet structure, stability, and taste, allowing for easy oral administration while maintaining consistent therapeutic activity of the active compound.

Ivermectin Oral Paste is a broad-spectrum antiparasitic formulation commonly used in veterinary medicine, particularly for horses. It typically contains ivermectin as the active ingredient, sometimes combined with other agents like praziquantel to expand its efficacy against both internal and external parasites. This combination is effective in treating and controlling a wide range of parasites, including large and small strongyles, pinworms, ascarids, bots, lungworms, and tapeworms. The oral paste is easy to administer, designed to ensure accurate dosing based on the animal's weight, and is flavored to improve palatability. It is a trusted choice for routine deworming protocols and overall parasite management in equine care.

Fluralaner 1000 mg tablets are a long-acting ectoparasiticide used for the treatment and control of flea and tick infestations in dogs. Formulated for oral administration, fluralaner belongs to the isoxazoline class of compounds and works by inhibiting the nervous system of parasites, leading to rapid elimination of fleas and ticks. A single tablet provides extended protection, typically up to 12 weeks, helping to prevent re-infestation and reduce the risk of flea- and tick-borne diseases. The tablet is generally palatable, easy to administer, and suitable for dogs of appropriate body weight as prescribed by a veterinarian, ensuring effective and convenient parasite control.

Olacitinib Maleate Tablets 5.4 mg is a pharmaceutical formulation primarily containing Olacitinib, a Janus kinase (JAK) inhibitor used to modulate immune response and reduce inflammation. This tablet may be combined with suitable excipients such as microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and magnesium stearate to ensure stability, absorption, and bioavailability. Designed for oral administration, Olacitinib Maleate is often indicated for managing inflammatory or autoimmune conditions such as atopic dermatitis or other JAK-responsive disorders. The combination is formulated to provide consistent therapeutic levels, minimize gastrointestinal irritation, and ensure patient compliance with a convenient once-daily dosing regimen.